Design, synthesis and evaluation of (E)-α-benzylthio chalcones as novel inhibitors of BCR-ABL kinase

Design, synthesis and evaluation of (E)-α-benzylthio chalcones as novel inhibitors of BCR-ABL kinase Hybrid compounds as new Bcr/Abl inhibitors Design, synthesis and biological evaluation of novel acrylamide analogues as inhibitors of BCR–ABL kinase Synthesis and biological evaluation of novel aromatic-heterocyclic biphenyls as potent anti-leukemia agents Synthesis and biological evaluation of novel aromatic amide derivatives as potential BCR-ABL inhibitors Design and synthesis of 3-substituted benzamide derivatives as Bcr-Abl kinase inhibitors Design, synthesis, and biological activity of 4-(imidazo[1,2- b ]pyridazin-3-yl)-1 H -pyrazol-1-yl-phenylbenzamide derivatives as BCR–ABL kinase inhibitors Discovery of New Benzothiazole-Based Inhibitors of Breakpoint Cluster Region-Abelson Kinase Including the T315I Mutant Expanding the structural diversity of Bcr-Abl inhibitors: Hybrid molecules based on GNF-2 and Imatinib Discovery of novel Bcr–Abl inhibitors targeting myristoyl pocket and ATP site